Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 16

The DOI matches its Crossref record.

Ginger for Prevention of Antituberculosis-induced Gastrointestinal Adverse Reactions Including Hepatotoxicity: A Randomized Pilot Clinical Trial: Ginger and Antituberculosis Adverse Reactions

Emrani, Zahra, Shojaei, Esphandiar, Khalili, Hossein · 2016 · Phytotherapy Research

Abstract

In this study, the potential benefits of ginger in preventing antituberculosis drug-induced gastrointestinal adverse reactions including hepatotoxicity have been evaluated in patients with tuberculosis. Patients in the ginger and placebo groups (30 patients in each group) received either 500 mg ginger (Zintoma)(®) or placebo one-half hour before each daily dose of antituberculosis drugs for 4 weeks. Patients' gastrointestinal complaints (nausea, vomiting, dyspepsia, and abdominal pain) and antituberculosis drug-induced hepatotoxicity were recorded during the study period. In this cohort, nausea was the most common antituberculosis drug-induced gastrointestinal adverse reactions. Forty eight (80%) patients experienced nausea. Nausea was more common in the placebo than the ginger group [27 (90%) vs 21 (70%), respectively, p = 0.05]. During the study period, 16 (26.7%) patients experienced antituberculosis drug-induced hepatotoxicity. Patients in the ginger group experienced less, but not statistically significant, antituberculosis drug-induced hepatotoxicity than the placebo group (16.7% vs 36.7%, respectively, p = 0.07). In conclusion, ginger may be a potential option for prevention of antituberculosis drug-induced gastrointestinal adverse reactions including hepatotoxicity. Copyright © 2016 John Wiley & Sons, Ltd.

Overview

Integrity signals

Registry

Crossref · 10.1002/ptr.5607

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 38

  1. Ali, 2008, Some phytochemical, pharmacological and toxicological properties of ginger: a review of recent research, Food Chem Toxicol, 46, 409, 10.1016/j.fct.2007.09.085 · DOI · Paper page
  2. Altug, 2013, Effect of ginger extract on liver damage in experimental obstructive jaundice produced by main bile duct ligation, Acta Chir Belg, 113, 8, 10.1080/00015458.2013.11680877 · doi:10.1080/00015458.2013.11680877
  3. Atta, 2010, Hepatoprotective effect of methanol extracts of zingiberofficinale and cichoriumintybus, Indian J Pharm Sci, 72, 564, 10.4103/0250-474X.78521 · doi:10.4103/0250-474x.78521
  4. Becker, 2010, Nausea, vomiting, and hiccups: a review of mechanisms and treatment, Anesth Prog, 57, 150, 10.2344/0003-3006-57.4.150 · DOI · Paper page
  5. ClarkVetri, 1999, Management of chemotherapy induced emesis, Pharm Times, 65, 7885
  6. Dabaghzadeh, 2014a, Ginger for prevention or treatment of drug-induced nausea and vomiting, Curr Clin Pharmacol, 9, 387, 10.2174/1574884708666131111205736 · DOI
  7. Dabaghzadeh, 2014b, Ginger for prevention of antiretroviral-induced nausea and vomiting: a randomized clinical trial, Expert Opin Drug Saf, 13, 859, 10.1517/14740338.2014.914170 · DOI · Paper page
  8. Danan, 1993, Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries, J Clin Epidemiol, 46, 1323, 10.1016/0895-4356(93)90101-6 · DOI · Paper page
  9. Ergul, 2010, Effect of vitamin C on oxidative liver injury due to isoniazid in rats, Pediatr Int, 52, 69, 10.1111/j.1442-200X.2009.02891.x · DOI
  10. Farazi, 2014, Adverse reactions to antituberculosis drugs in Iranian tuberculosis patients, Tuberc Res Treat, 2014
  11. Haniadka, 2013, Ginger protects the liver against the toxic effects of xenobiotic compounds: preclinical observations, J Nutr Food Sci, 3, 226
  12. Hatamkhani, 2014, Carnitine for prevention of antituberculosis drug-induced hepatotoxicity: a randomized, clinical trial, J Gastroenterol Hepatol, 29, 997, 10.1111/jgh.12474 · DOI
  13. Khalili, 2008, Assessment of adherence to tuberculosis drug regimen, DARU, 16, 47
  14. Khalili, 2009, Anti-tuberculosis drugs related hepatotoxicity; incidence, risk factors, pattern of changes in liver enzymes and outcome, DARU, 17, 163
  15. Langner, 1998, Ginger: history and use, Adv Ther, 15, 25
  16. Liu, 2008, Drugs and herbs given to prevent hepatotoxicity of tuberculosis therapy: systematic review of ingredients and evaluation studies, BMC Public Health, 8, 365, 10.1186/1471-2458-8-365 · doi:10.1186/1471-2458-8-365
  17. Maciel, 2010, Adverse effects of the new tuberculosis treatment regimen recommended by the Brazilian Ministry of Health, J Bras Pneumol, 36, 232, 10.1590/S1806-37132010000200012 · doi:10.1590/s1806-37132010000200012
  18. Mahesh, 2005, Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods, Pharmazie, 60, 83
  19. Motawi, 2011, Zingiber officinale acts as a nutraceutical agent against liver fibrosis. Nutr Metab 2011;8:40. 47. Sahebkar A. Potential efficacy of ginger as a natural supplement for nonalcoholic fatty liver disease, World J Gastroenterol, 17, 271
  20. Naranjo, 1981, A method for estimating the probability of adverse drug reactions, Clin Pharmacol Ther, 30, 239, 10.1038/clpt.1981.154 · DOI · Paper page
  21. Pertz, 2011, Effects of ginger constituents on the gastrointestinal tract: role of cholinergic M3 and serotonergic 5-HT3 and 5-HT4 receptors, Planta Med, 77, 973, 10.1055/s-0030-1270747 · DOI
  22. Pradier, 2006, A trial of a mixture of three essential oils in the treatment of postoperative nausea and vomiting, Int J Aromather, 16, 15, 10.1016/j.ijat.2006.01.004 · doi:10.1016/j.ijat.2006.01.004
  23. Qian, 2009, Gingerol inhibits cisplatin-induced vomiting by down regulating 5-hydroxytryptamine, dopamine and substance P expression in minks, Arch. Pharm. Res., 32, 565, 10.1007/s12272-009-1413-9 · DOI
  24. Qian, 2010, Effect of gingerol on substance P and NK1 receptor expression in a vomiting model of mink, Chin Med J, 123, 478
  25. Ramappa, 2013, Hepatotoxicity related to anti-tuberculosis drugs: mechanisms and management, J Clin Exp Hepatol, 3, 37, 10.1016/j.jceh.2012.12.001 · DOI · Paper page
  26. Saad, 2010, Role of oxidative stress and nitric oxide in the protective effects of alpha-lipoic acid and aminoguanidine against isoniazid-rifampicin-induced hepatotoxicity in rats, Food Chem Toxicol, 48, 1869, 10.1016/j.fct.2010.04.026 · doi:10.1016/j.fct.2010.04.026
  27. Saukkonen, 2006, An official ATS statement: hepatotoxicity of antituberculosis therapy, Am J Respir Crit Care Med, 174, 935, 10.1164/rccm.200510-1666ST · DOI · Paper page
  28. Schmid, 1994, Comparison of seven commonly used agents for prophylaxis of seasickness, J Travel Med, 1, 203, 10.1111/j.1708-8305.1994.tb00596.x · DOI
  29. Sistanizad, 2011, Antituberculosis drug-induced hepatotoxicity in Iranian tuberculosis patients: role of isoniazid metabolic polymorphism, Iran J Pharm Res, 10, 633
  30. Steele, 1991, Toxic hepatitis with isoniazid and rifampin. A meta-analysis, Chest, 99, 465, 10.1378/chest.99.2.465 · DOI · Paper page
  31. Sukhanov, 2012, Effectiveness of the hepatoprotective activity of reamberine, remaxol, and ademethionine and risk assessment in their use in patients with respiratory tuberculosis and drug-induced liver injury, Ter Arkh, 84, 26
  32. Swamy, 2012, Hepatoprotective effect of cissus quadrangularis stem extract against rifampicin-induced hepatotoxicity in rats, Indian J Pharm Sci, 74, 183, 10.4103/0250-474X.103859 · DOI
  33. Taramian, 2012, Side effects of first-line anti tuberculosis drugs, J Guilan Univ Med Sci, 85, 42
  34. Tasduq, 2005, Biochemical manifestations of anti-tuberculosis drugs induced hepatotoxicity and the effect of silymarin, Hepatol Res, 31, 132, 10.1016/j.hepres.2005.01.005 · DOI
  35. Thompson, 1995, Anti-tuberculosis medication and the liver: dangers and recommendations in management, Eur Respir J, 8, 1384, 10.1183/09031936.95.08081384 · DOI
  36. Tostmann, 2008, Antituberculosis drug-induced hepatotoxicity: concise up-to-date review, J Gastroenterol Hepatol, 23, 192, 10.1111/j.1440-1746.2007.05207.x · DOI · Paper page
  37. White, 2007, Ginger: an overview, Am Fam Physician, 75, 1689
  38. Xia, 2007, Systematic review of anti-tuberculosis drug induced adverse reactions in China, Chin J Tuberc Respir Dis (Zhonghua Jie He He Hu Xi Za Zhi), 30, 419

Cited by

See all 16

Metadata

Authors
Emrani, Z., Shojaei, E., & Khalili, H.
Affiliations
  • Department of Clinical Pharmacy, Faculty of Pharmacy; Tehran University of Medical Sciences; Tehran Iran
  • Department of Infectious Diseases, Faculty of Medicine; Tehran University of Medical Sciences; Tehran Iran
Venue
Phytotherapy Research
Publisher
Wiley
Published
2016-03-07
Volume
30
Issue
6
Pages
1003-1009
ISSN
0951-418X
Cited by
16
References
0
Language
en
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
Funders
Office of Vice-Chancellor for Research of Tehran University of Medical Sciences

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ginger for Prevention of Antituberculosis-induced Gastrointestinal Adverse Reactions Including Hepatotoxicity: A Randomized Pilot Clinical Trial: Ginger and Antituberculosis Adverse Reactions. https://app.cochat.ai/papers/10.1002/ptr.5607
The paper
Emrani, Z., Shojaei, E., & Khalili, H. (2016). Ginger for Prevention of Antituberculosis-induced Gastrointestinal Adverse Reactions Including Hepatotoxicity: A Randomized Pilot Clinical Trial: Ginger and Antituberculosis Adverse Reactions. Phytotherapy Research. https://doi.org/10.1002/ptr.5607

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.